- Vyvanse: Uses, Taking, Side Effects, Warnings - Medicine. com
Vyvanse is a federally controlled substance CII and CNS stimulant used to treat attention deficit hyperactivity disorder (ADHD) and binge eating disorder (BED)
- medication guide - Food and Drug Administration
[Vī’ VYVANSE MEDICATION GUIDE ® -văns] (lisdexamfetamine dimesylate) CII Capsules Read the Medication Guide that comes with Vyvanse before you or your child starts taking it and
- Lisdexamfetamine: Side Effects, Dosage, Uses, and More - Healthline
Lisdexamfetamine is a prescription drug It comes as an oral capsule and an oral chewable tablet Lisdexamfetamine oral capsule is available as the brand-name drug Vyvanse
- VYVANSE (lisdexamfetamine dimesylate) Capsules FULL PRESCRIBING . . .
VYVANSE® (lisdexamfetamine dimesylate) Capsules FULL PRESCRIBING INFORMATION WARNING: ABUSE AND DEPENDENCE CNS stimulants
- VYVANSE - PLM
INDICACIONES TERAPÉUTICAS: Trastorno por Déficit de Atención con Hiperactividad: VYVANSE está indicado para el tratamiento de trastorno por déficit de atención con hiperactividad (TDAH) La eficacia del VYVANSE en el tratamiento del TDAH se ha demostrado en tres ensayos clínicos controlados en los niños con edades comprendidas entre los 6 y 12 años, un estudio controlado en
- Vyvanse Interactions Checker - Drugs. com
Vyvanse Interactions There are 395 drugs known to interact with Vyvanse (lisdexamfetamine), along with 10 disease interactions, and 3 alcohol food interactions Of the total drug interactions, 100 are major, 286 are moderate, and 9 are minor
- Vyvanse: Package Insert Prescribing Information - Drugs. com
Risks to Patients with Serious Cardiac Disease: Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmia, coronary artery disease, or other serious cardiac disease Increased Blood Pressure and Heart Rate: Monitor blood pressure and pulse (Psychiatric Adverse Reactions: Prior to initiating VYVANSE, screen patients for risk factors for
- [Product Monograph Template - Standard]
Page 1 of 60 PRODUCT MONOGRAPH VYVANSE®* lisdexamfetamine dimesylate Capsules: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg Chewable Tablets: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg Central Nervous System Stimulant Shire Pharma Canada ULC
|